The toxicity of environmental and dietary ligands of the aryl hydrocarbon receptor (AhR) in mature liver parenchymal cells is well appreciated, while considerably less attention has been paid to their impact on cell populations exhibiting phenotypic features of liver progenitor cells. Here, we discuss the results suggesting that the consequences of the AhR activation in the cellular models derived from bipotent liver progenitors could markedly differ from those in hepatocytes. In contact-inhibited liver progenitor cells, the AhR agonists induce a range of effects potentially linked with tumor promotion. They can stimulate cell cycle progression/proliferation and deregulate cell-to-cell communication, which is associated with downregulation of proteins forming gap junctions, adherens junctions, and desmosomes (such as connexin 43, E-cadherin, β-catenin, and plakoglobin), as well as with reduced cell adhesion and inhibition of intercellular communication. At the same time, toxic AhR ligands may affect the activity of the signaling pathways contributing to regulation of liver progenitor cell activation and/or differentiation, such as downregulation of Wnt/β-catenin and TGF-β signaling, or upregulation of transcriptional targets of YAP/TAZ, the effectors of Hippo signaling pathway. These data illustrate the need to better understand the potential role of liver progenitors in the AhR-mediated liver carcinogenesis and tumor promotion.

Department of Chemistry and Toxicology Veterinary Research Institute 62100 Brno Czech Republic

Department of Cytokinetics Institute of Biophysics of the Czech Academy of Sciences 61265 Brno Czech Republic

Zobrazit více v PubMed

Grisham J. W. Organization principles of the liver. In: Arias I., Wolkoff A., Boyer J., et al., editors. The Liver: Biology and Pathobiology. Hoboken, NJ, USA: Wiley-Blackwell; 2009. pp. 3–15.

Stanger B. Z. Cellular homeostasis and repair in the mammalian liver. Annual Review of Physiology. 2015;77:179–200. doi: 10.1146/annurev-physiol-021113-170255. PubMed DOI PMC

Michalopoulos G. K., DeFrances M. C. Liver regeneration. Science. 1997;276(5309):60–65. doi: 10.1126/science.276.5309.60. PubMed DOI

Malato Y., Naqvi S., Schürmann N., et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. The Journal of Clinical Investigation. 2011;121(12):4850–4860. doi: 10.1172/jci59261. PubMed DOI PMC

Michalopoulos G. K., Khan Z. Liver stem cells: experimental findings and implications for human liver disease. Gastroenterology. 2015;149(4):876–882. doi: 10.1053/j.gastro.2015.08.004. PubMed DOI PMC

Miyajima A., Tanaka M., Itoh T. Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell. 2014;14(5):561–574. doi: 10.1016/j.stem.2014.04.010. PubMed DOI

Riehle K. J., Dan Y. Y., Campbell J. S., Fausto N. New concepts in liver regeneration. Journal of Gastroenterology and Hepatology. 2011;26(supplement 1):203–212. doi: 10.1111/j.1440-1746.2010.06539.x. PubMed DOI PMC

Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39(6):1477–1487. doi: 10.1002/hep.20214. PubMed DOI

Thorgeirsson S. S., Grisham J. W. Overview of recent experimental studies on liver stem cells. Seminars in Liver Disease. 2003;23(4):303–312. doi: 10.1055/s-2004-815559. PubMed DOI

Budinsky R. A., Schrenk D., Simon T., et al. Mode of action and dose-response framework analysis for receptor-mediated toxicity: the aryl hydrocarbon receptor as a case study. Critical Reviews in Toxicology. 2014;44(1):83–119. doi: 10.3109/10408444.2013.835787. PubMed DOI

Roskams T. A., Libbrecht L., Desmet V. J. Progenitor cells in diseased human liver. Seminars in Liver Disease. 2003;23(4):385–396. doi: 10.1055/s-2004-815564. PubMed DOI

Turányi E., Dezsö K., Csomor J., Schaff Z., Paku S., Nagy P. Immunohistochemical classification of ductular reactions in human liver. Histopathology. 2010;57(4):607–614. doi: 10.1111/j.1365-2559.2010.03668.x. PubMed DOI

Alison M. R. Characterization of the differentiation capacity of rat-derived hepatic stem cells. Seminars in Liver Disease. 2003;23(4):325–336. doi: 10.1055/s-2004-815561. PubMed DOI

Akhurst B., Croager E. J., Farley-Roche C. A., et al. A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology. 2001;34(3):519–522. doi: 10.1053/jhep.2001.26751. PubMed DOI

Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Research. 1956;16:142–148. PubMed

Leduc E. H., Wilson J. W. Injury to liver cells in carbon tetrachloride poisoning; histochemical changes induced by carbon tetrachloride in mouse liver protected by sulfaguanidine. AMA Archives of Pathology. 1958;65(2):147–157. PubMed

Preisegger K.-H., Factor V. M., Fuchsbichler A., Stumptner C., Denk H., Thorgeirsson S. S. Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Laboratory Investigation. 1999;79(2):103–109. PubMed

Dunsford H. A., Karnasuta C., Hunt J. M., Sell S. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Research. 1989;49(17):4894–4900. PubMed

Lázaro C. A., Rhim J. A., Yamada Y., Fausto N. Generation of hepatocytes from oval cell precursors in culture. Cancer Research. 1998;58(23):5514–5522. PubMed

Paku S., Schnur J., Nagy P., Thorgeirsson S. S. Origin and structural evolution of the early proliferating oval cells in rat liver. The American Journal of Pathology. 2001;158(4):1313–1323. doi: 10.1016/s0002-9440(10)64082-5. PubMed DOI PMC

Yanger K., Zong Y., Maggs L. R., et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes & Development. 2013;27(7):719–724. PubMed PMC

Tarlow B. D., Pelz C., Naugler W. E., et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell. 2014;15(5):605–618. doi: 10.1016/j.stem.2014.09.008. PubMed DOI PMC

Kordes C., Sawitza I., Götze S., Herebian D., Häussinger D. Hepatic stellate cells contribute to progenitor cells and liver regeneration. The Journal of Clinical Investigation. 2014;124(12):5503–5515. doi: 10.1172/jci74119. PubMed DOI PMC

Michelotti G. A., Xie G., Swiderska M., et al. Smoothened is a master regulator of adult liver repair. The Journal of Clinical Investigation. 2013;123(6):2380–2394. doi: 10.1172/jci66904. PubMed DOI PMC

Itoh T., Miyajima A. Liver regeneration by stem/progenitor cells. Hepatology. 2014;59(4):1617–1626. doi: 10.1002/hep.26753. PubMed DOI

Lu W.-Y., Bird T. G., Boulter L., et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nature Cell Biology. 2015;17:971–983. doi: 10.1038/ncb3203. PubMed DOI PMC

Dorrell C., Erker L., Schug J., et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes & Development. 2011;25(11):1193–1203. doi: 10.1101/gad.2029411. PubMed DOI PMC

Huch M., Dorrell C., Boj S. F., et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature. 2013;494(7436):247–250. doi: 10.1038/nature11826. PubMed DOI PMC

Okabe M., Tsukahara Y., Tanaka M., et al. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development. 2009;136(11):1951–1960. doi: 10.1242/dev.031369. PubMed DOI

Shin S., Walton G., Aoki R., et al. Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes and Development. 2011;25(11):1185–1192. doi: 10.1101/gad.2027811. PubMed DOI PMC

Huch M., Gehart H., Van Boxtel R., et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160(1-2):299–312. doi: 10.1016/j.cell.2014.11.050. PubMed DOI PMC

Furuyama K., Kawaguchi Y., Akiyama H., et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nature Genetics. 2011;43(1):34–41. doi: 10.1038/ng.722. PubMed DOI

Rodrigo-Torres D., Affò S., Coll M., et al. The biliary epithelium gives rise to liver progenitor cells. Hepatology. 2014;60(4):1367–1377. doi: 10.1002/hep.27078. PubMed DOI PMC

Español-Suñer R., Carpentier R., Van Hul N., et al. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology. 2012;143(6):1564–1575.e7. doi: 10.1053/j.gastro.2012.08.024. PubMed DOI

Schaub J. R., Malato Y., Gormond C., Willenbring H. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Reports. 2014;8(4):933–939. doi: 10.1016/j.celrep.2014.07.003. PubMed DOI PMC

Yanger K., Knigin D., Zong Y., et al. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell. 2014;15(3):340–349. doi: 10.1016/j.stem.2014.06.003. PubMed DOI PMC

Font-Burgada J., Shalapour S., Ramaswamy S., et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell. 2015;162(4):766–779. doi: 10.1016/j.cell.2015.07.026. PubMed DOI PMC

Wang B., Zhao L., Fish M., Logan C. Y., Nusse R. Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature. 2015;524(7564):180–185. doi: 10.1038/nature14863. PubMed DOI PMC

Jörs S., Jeliazkova P., Ringelhan M., et al. Lineage fate of ductular reactions in liver injury and carcinogenesis. The Journal of Clinical Investigation. 2015;125(6):2445–2457. doi: 10.1172/jci78585. PubMed DOI PMC

Chiba T., Zheng Y.-W., Kita K., et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology. 2007;133(3):937–950. doi: 10.1053/j.gastro.2007.06.016. PubMed DOI

Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25(27):3818–3822. doi: 10.1038/sj.onc.1209558. PubMed DOI

Lo R. C., Ng I. O. Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. Liver Cancer. 2013;2(2):84–92. PubMed PMC

Coulouarn C., Cavard C., Rubbia-Brandt L., et al. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways. Carcinogenesis. 2012;33(9):1791–1796. doi: 10.1093/carcin/bgs208. PubMed DOI

McIntosh B. E., Hogenesch J. B., Bradfield C. A. Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annual Review of Physiology. 2009;72:625–645. doi: 10.1146/annurev-physiol-021909-135922. PubMed DOI

Nebert D. W., Dalton T. P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nature Reviews Cancer. 2006;6(12):947–960. doi: 10.1038/nrc2015. PubMed DOI

Barouki R., Coumoul X., Fernandez-Salguero P. M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Letters. 2007;581(19):3608–3615. doi: 10.1016/j.febslet.2007.03.046. PubMed DOI

Bock K. W., Köhle C. Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochemical Pharmacology. 2005;69(10):1403–1408. doi: 10.1016/j.bcp.2005.02.004. PubMed DOI

Dietrich C., Kaina B. The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis. 2010;31(8):1319–1328. doi: 10.1093/carcin/bgq028. PubMed DOI PMC

Kung T., Murphy K. A., White L. A. The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochemical Pharmacology. 2009;77(4):536–546. doi: 10.1016/j.bcp.2008.09.031. PubMed DOI PMC

Puga A., Ma C., Marlowe J. L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochemical Pharmacology. 2009;77(4):713–722. doi: 10.1016/j.bcp.2008.08.031. PubMed DOI PMC

Mitchell K. A., Elferink C. J. Timing is everything: consequences of transient and sustained AhR activity. Biochemical Pharmacology. 2009;77(6):947–956. doi: 10.1016/j.bcp.2008.10.028. PubMed DOI PMC

Fernandez-Salguero P., Pineau T., Hilbert D. M., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 1995;268(5211):722–726. doi: 10.1126/science.7732381. PubMed DOI

Schmidt J. V., Su G. H.-T., Reddy J. K., Simon M. C., Bradfield C. A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(13):6731–6736. doi: 10.1073/pnas.93.13.6731. PubMed DOI PMC

Walisser J. A., Glover E., Pande K., Liss A. L., Bradfield C. A. Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(49):17858–17863. doi: 10.1073/pnas.0504757102. PubMed DOI PMC

Poland A., Knutson J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology. 1982;22:517–554. doi: 10.1146/annurev.pa.22.040182.002505. PubMed DOI

Pohjanvirta R., Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacological Reviews. 1994;46(4):483–549. PubMed

Van den Berg M., Birnbaum L., Bosveld A. T. C., et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environmental Health Perspectives. 1998;106(12):775–792. doi: 10.1289/ehp.98106775. PubMed DOI PMC

Walker N. J., Crockett P. W., Nyska A., et al. Dose-additive carcinogenicity of a defined mixture of ‘dioxin-like compounds’. Environmental Health Perspectives. 2005;113(1):43–48. doi: 10.1289/ehp.7351. PubMed DOI PMC

Kennedy G. D., Nukaya M., Moran S. M., et al. Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors. Toxicological Sciences. 2014;140(1):135–143. doi: 10.1093/toxsci/kfu065. PubMed DOI PMC

Pitot H. C., Goldsworthy T., Campbell H. A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Research. 1980;40(10):3616–3620. PubMed

IARC. Chemical Agents and Related Occupations—A Review of Human Carcinogens. Lyon, France: IARC; 2012.

Knerr S., Schrenk D. Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models. Molecular Nutrition and Food Research. 2006;50(10):897–907. doi: 10.1002/mnfr.200600006. PubMed DOI

National Toxicology Program. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies) National Toxicology Program Technical Report Series. 2006;(521):4–232. PubMed

National Toxicology Program. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies) National Toxicology Program Technical Report Series. 2006;531:1–218. PubMed

Hailey J. R., Walker N. J., Sells D. M., Brix A. E., Jokinen M. P., Nyska A. Classification of proliferative hepatocellular lesions in Harlan Sprague-Dawley rats chronically exposed to dioxin-like compounds. Toxicologic Pathology. 2005;33(1):165–174. doi: 10.1080/01926230590888324. PubMed DOI

Bennett J. A., Singh K. P., Unnisa Z., Welle S. L., Gasiewicz T. A. Deficiency in aryl hydrocarbon receptor (AHR) expression throughout aging alters gene expression profiles in murine long-term hematopoietic stem cells. PLoS ONE. 2015;10(7) doi: 10.1371/journal.pone.0133791.e0133791 PubMed DOI PMC

Boitano A. E., Wang J., Romeo R., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science. 2010;329(5997):1345–1348. doi: 10.1126/science.1191536. PubMed DOI PMC

Bunaciu R. P., Yen A. Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4. Cancer Research. 2011;71(6):2371–2380. doi: 10.1158/0008-5472.can-10-2299. PubMed DOI PMC

Casado F. L., Singh K. P., Gasiewicz T. A. Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Molecular Pharmacology. 2011;80(4):673–682. doi: 10.1124/mol.111.071381. PubMed DOI PMC

Roeven M. W., Thordardottir S., Kohela A., et al. The aryl hydrocarbon receptor antagonist stemregenin1 improves in vitro generation of highly functional natural killer cells from CD34+ hematopoietic stem and progenitor cells. Stem Cells and Development. 2015;24(24):2886–2898. doi: 10.1089/scd.2014.0597. PubMed DOI

Singh K. P., Garrett R. W., Casado F. L., Gasiewicz T. A. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. Stem Cells and Development. 2011;20(5):769–784. doi: 10.1089/scd.2010.0333. PubMed DOI PMC

Xu T., Zhou Y., Qiu L., et al. Aryl hydrocarbon receptor protects lungs from cockroach allergen-induced inflammation by modulating mesenchymal stem cells. The Journal of Immunology. 2015;195(12):5539–5550. doi: 10.4049/jimmunol.1501198. PubMed DOI PMC

Contador-Troca M., Alvarez-Barrientos A., Merino J. M., et al. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis. Molecular Cancer. 2015;14(1, article 148) doi: 10.1186/s12943-015-0419-9. PubMed DOI PMC

Prud'Homme G. J., Glinka Y., Toulina A., Ace O., Subramaniam V., Jothy S. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. PLoS ONE. 2010;5(11) doi: 10.1371/journal.pone.0013831.e13831 PubMed DOI PMC

Harrill J. A., Parks B. B., Wauthier E., Rowlands J. C., Reid L. M., Thomas R. S. Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis. Hepatology. 2015;61(2):548–560. doi: 10.1002/hep.27547. PubMed DOI PMC

Feng S., Cao Z., Wang X. Role of aryl hydrocarbon receptor in cancer. Biochimica et Biophysica Acta-Reviews on Cancer. 2013;1836(2):197–210. doi: 10.1016/j.bbcan.2013.05.001. PubMed DOI

Murray I. A., Patterson A. D., Perdew G. H. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nature Reviews Cancer. 2014;14(12):801–814. doi: 10.1038/nrc3846. PubMed DOI PMC

Safe S., Lee S.-O., Jin U.-H. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicological Sciences. 2013;135(1):1–16. doi: 10.1093/toxsci/kft128. PubMed DOI PMC

Fan Y., Boivin G. P., Knudsen E. S., Nebert D. W., Xia Y., Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Research. 2010;70(1):212–220. doi: 10.1158/0008-5472.CAN-09-3090. PubMed DOI PMC

Moennikes O., Loeppen S., Buchmann A., et al. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Research. 2004;64(14):4707–4710. doi: 10.1158/0008-5472.CAN-03-0875. PubMed DOI

Hanahan D., Weinberg R. A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013. PubMed DOI

Nahta R., Al-Mulla F., Al-Temaimi R., et al. Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression. Carcinogenesis. 2015;36(supplement 1):S2–S18. doi: 10.1093/carcin/bgv028. PubMed DOI PMC

Ma Q., Whitlock J. P., Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Molecular and Cellular Biology. 1996;16(5):2144–2150. doi: 10.1128/MCB.16.5.2144. PubMed DOI PMC

Weiss C., Kolluri S. K., Kiefer F., Göttlicher M. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Experimental Cell Research. 1996;226(1):154–163. doi: 10.1006/excr.1996.0214. PubMed DOI

Kolluri S. K., Weiss C., Koff A., Göttlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes and Development. 1999;13(13):1742–1753. doi: 10.1101/gad.13.13.1742. PubMed DOI PMC

Elferink C. J., Ge N.-L., Levine A. Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Molecular Pharmacology. 2001;59(4):664–673. PubMed

Ge N.-L., Elferink C. J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein: linking dioxin signaling to the cell cycle. Journal of Biological Chemistry. 1998;273(35):22708–22713. doi: 10.1074/jbc.273.35.22708. PubMed DOI

Puga A., Barnes S. J., Dalton T. P., Chang C.-Y., Knudsen E. S., Maier M. A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. The Journal of Biological Chemistry. 2000;275(4):2943–2950. doi: 10.1074/jbc.275.4.2943. PubMed DOI

Huang G., Elferink C. J. Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Molecular Pharmacology. 2005;67(1):88–96. doi: 10.1124/mol.104.002410. PubMed DOI

Marlowe J. L., Knudsen E. S., Schwemberger S., Puga A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. The Journal of Biological Chemistry. 2004;279(28):29013–29022. doi: 10.1074/jbc.m404315200. PubMed DOI

Elferink C. J. Aryl hydrocarbon receptor-mediated cell cycle control. Progress in Cell Cycle Research. 2003;5:261–267. PubMed

Puga A., Xia Y., Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chemico-Biological Interactions. 2002;141(1-2):117–130. doi: 10.1016/S0009-2797(02)00069-8. PubMed DOI

Jackson D. P., Li H., Mitchell K. A., Joshi A. D., Elferink C. J. Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression. Molecular Pharmacology. 2014;85(4):533–541. doi: 10.1124/mol.113.089730. PubMed DOI PMC

Mitchell K. A., Lockhart C. A., Huang G., Elferink C. J. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Molecular Pharmacology. 2006;70(1):163–170. doi: 10.1124/mol.106.023465. PubMed DOI

Mitchell K. A., Wilson S. R., Elferink C. J. The activated aryl hydrocarbon receptor synergizes mitogen-induced murine liver hyperplasia. Toxicology. 2010;276(2):103–109. doi: 10.1016/j.tox.2010.07.004. PubMed DOI PMC

Tsao M.-S., Smith J. D., Nelson K. G., Grisham J. W. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of ‘oval’ cells. Experimental Cell Research. 1984;154(1):38–52. doi: 10.1016/0014-4827(84)90666-9. PubMed DOI

Shafritz D. A., Dabeva M. D. Liver stem cells and model systems for liver repopulation. Journal of Hepatology. 2002;36(4):552–564. doi: 10.1016/S0168-8278(02)00013-2. PubMed DOI

Köhle C., Gschaidmeier H., Lauth D., Topell S., Zitzer H., Bock K. W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Archives of Toxicology. 1999;73(3):152–158. PubMed

Dietrich C., Faust D., Budt S., et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicology and Applied Pharmacology. 2002;183(2):117–126. doi: 10.1016/s0041-008x(02)99475-5. PubMed DOI

Chramostová K., Vondráček J., Šindlerová L., Vojtěšek B., Kozubík A., Machala M. Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells. Toxicology and Applied Pharmacology. 2004;196(1):136–148. doi: 10.1016/j.taap.2003.12.008. PubMed DOI

Procházková J., Kozubík A., Machala M., Vondráček J. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells. Toxicology. 2011;279(1–3):146–154. doi: 10.1016/j.tox.2010.10.003. PubMed DOI

Vondráček J., Machala M., Bryja V., et al. Aryl hydrocarbon receptor-activating polychlorinated biphenyls and their hydroxylated metabolites induce cell proliferation in contact-inhibited rat liver epithelial cells. Toxicological Sciences. 2005;83(1):53–63. doi: 10.1093/toxsci/kfi009. PubMed DOI

Zatloukalová J., Švihálková-Šindlerová L., Kozubík A., Krčmář P., Machala M., Vondráček J. β-naphthoflavone and 3′-methoxy-4′-nitroflavone exert ambiguous effects on Ah receptor-dependent cell proliferation and gene expression in rat liver 'stem-like' cells. Biochemical Pharmacology. 2007;73(10):1622–1634. doi: 10.1016/j.bcp.2007.01.032. PubMed DOI

Andrysík Z., Vondráček J., Machala M., et al. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells. Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis. 2007;615(1-2):87–97. doi: 10.1016/j.mrfmmm.2006.10.004. PubMed DOI

Weiss C., Faust D., Schreck I., et al. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene. 2008;27(15):2198–2207. doi: 10.1038/sj.onc.1210859. PubMed DOI

Faust D., Kletting S., Ueberham E., Dietrich C. Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cells. Toxicology Letters. 2013;223(1):73–80. doi: 10.1016/j.toxlet.2013.08.022. PubMed DOI

Svobodová J., Kabátková M., Šmerdová L., et al. The aryl hydrocarbon receptor-dependent disruption of contact inhibition in rat liver WB-F344 epithelial cells is linked with induction of survivin, but not with inhibition of apoptosis. Toxicology. 2015;333:37–44. doi: 10.1016/j.tox.2015.04.001. PubMed DOI

Gripon P., Rumin S., Urban S., et al. Infection of a human hepatoma cell line by hepatitis B virus. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(24):15655–15660. doi: 10.1073/pnas.232137699. PubMed DOI PMC

Cerec V., Glaise D., Garnier D., et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology. 2007;45(4):957–967. doi: 10.1002/hep.21536. PubMed DOI

Andrysík Z., Procházková J., Kabátková M., et al. Aryl hydrocarbon receptor-mediated disruption of contact inhibition is associated with connexin43 downregulation and inhibition of gap junctional intercellular communication. Archives of Toxicology. 2013;87(3):491–503. doi: 10.1007/s00204-012-0963-7. PubMed DOI

Procházková J., Kabátková M., Bryja V., et al. The interplay of the aryl hydrocarbon receptor and β-catenin alters both AhR-dependent transcription and wnt/β-catenin signaling in liver progenitors. Toxicological Sciences. 2011;122(2):349–360. doi: 10.1093/toxsci/kfr129. PubMed DOI

Procházková J., Kabátková M., Ŝmerdová L., et al. Aryl hydrocarbon receptor negatively regulates expression of the plakoglobin gene (Jup) Toxicological Sciences. 2013;134(2):258–270. doi: 10.1093/toxsci/kft110. PubMed DOI

Dong B., Cheng W., Li W., et al. FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. Biochimica et Biophysica Acta—General Subjects. 2011;1810(4):427–431. doi: 10.1016/j.bbagen.2010.11.007. PubMed DOI PMC

Rey-Barroso J., Colo G. P., Alvarez-Barrientos A., et al. The dioxin receptor controls β1 integrin activation in fibroblasts through a Cbp–Csk–Src pathway. Cellular Signalling. 2013;25(4):848–859. doi: 10.1016/j.cellsig.2013.01.010. PubMed DOI

Tomkiewicz C., Herry L., Bui L.-C., et al. The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway. Oncogene. 2013;32(14):1811–1820. doi: 10.1038/onc.2012.197. PubMed DOI

Dietrich C., Faust D., Moskwa M., Kunz A., Bock K.-W., Oesch F. TCDD-dependent downregulation of γ-catenin in rat liver epithelial cells (WB-F344) International Journal of Cancer. 2003;103(4):435–439. doi: 10.1002/ijc.10830. PubMed DOI

Gumbiner B. M., Kim N.-G. The Hippo-YAP signaling pathway and contact inhibition of growth. Journal of Cell Science. 2014;127(4):709–717. doi: 10.1242/jcs.140103. PubMed DOI PMC

McClatchey A. I., Yap A. S. Contact inhibition (of proliferation) redux. Current Opinion in Cell Biology. 2012;24(5):685–694. doi: 10.1016/j.ceb.2012.06.009. PubMed DOI

Faust D., Vondráček J., Krčmář P., et al. AhR-mediated changes in global gene expression in rat liver progenitor cells. Archives of Toxicology. 2013;87(4):681–698. doi: 10.1007/s00204-012-0979-z. PubMed DOI

Anastas J. N., Moon R. T. WNT signalling pathways as therapeutic targets in cancer. Nature Reviews Cancer. 2013;13(1):11–26. doi: 10.1038/nrc3419. PubMed DOI

Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149(6):1192–1205. doi: 10.1016/j.cell.2012.05.012. PubMed DOI

MacDonald B. T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Developmental Cell. 2009;17(1):9–26. doi: 10.1016/j.devcel.2009.06.016. PubMed DOI PMC

Balda M. S., Matter K. Epithelial cell adhesion and the regulation of gene expression. Trends in Cell Biology. 2003;13(6):310–318. doi: 10.1016/S0962-8924(03)00105-3. PubMed DOI

Monga S. P. S. Role and regulation of β-catenin signaling during physiological liver growth. Gene Expression. 2014;16(2):51–62. doi: 10.3727/105221614x13919976902138. PubMed DOI PMC

Monga S. P. β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology. 2015;148(7):1294–1310. doi: 10.1053/j.gastro.2015.02.056. PubMed DOI PMC

Apte U., Thompson M. D., Cui S., Liu B., Cieply B., Monga S. P. S. Wnt/β-catenin signaling mediates oval cell response in rodents. Hepatology. 2008;47(1):288–295. doi: 10.1002/hep.21973. PubMed DOI

Boulter L., Govaere O., Bird T. G., et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nature Medicine. 2012;18(4):572–579. doi: 10.1038/nm.2667. PubMed DOI PMC

Hu M., Kurobe M., Jeong Y. J., et al. Wnt/β-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 2007;133(5):1579–1591. doi: 10.1053/j.gastro.2007.08.036. PubMed DOI

Mokkapati S., Niopek K., Huang L., et al. β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Research. 2014;74(16):4515–4525. doi: 10.1158/0008-5472.can-13-3275. PubMed DOI PMC

Soeda J., Mouralidarane A., Ray S., et al. The beta-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice. Hepatology. 2014;60(3):1023–1034. doi: 10.1002/hep.27266. PubMed DOI

Yang W., Yan H.-X., Chen L., et al. Wnt/β-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Research. 2008;68(11):4287–4295. doi: 10.1158/0008-5472.can-07-6691. PubMed DOI

Schneider A. J., Branam A. M., Peterson R. E. Intersection of AHR and Wnt signaling in development, health, and disease. International Journal of Molecular Sciences. 2014;15(10):17852–17885. doi: 10.3390/ijms151017852. PubMed DOI PMC

Braeuning A., Sanna R., Huelsken J., Schwarz M. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of ctnnb1. Drug Metabolism and Disposition. 2009;37(5):1138–1145. doi: 10.1124/dmd.108.026179. PubMed DOI

Chesire D. R., Dunn T. A., Ewing C. M., Luo J., Isaacs W. B. Identification of aryl hydrocarbon receptor as a putative Wnt/β-catenin pathway target gene in prostate cancer cells. Cancer Research. 2004;64(7):2523–2533. doi: 10.1158/0008-5472.can-03-3309. PubMed DOI

Benhamouche S., Decaens T., Godard C., et al. Apc tumor suppressor gene is the ‘zonation-keeper’ of mouse liver. Developmental Cell. 2006;10(6):759–770. doi: 10.1016/j.devcel.2006.03.015. PubMed DOI

Gougelet A., Torre C., Veber P., et al. T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology. 2014;59(6):2344–2357. doi: 10.1002/hep.26924. PubMed DOI

Lindros K. O., Oinonen T., Johansson I., Ingelman-Sundberg M. Selective centrilobular expression of the aryl hydrocarbon receptor in rat liver. Journal of Pharmacology and Experimental Therapeutics. 1997;280(1):506–511. PubMed

Braeuning A., Köhle C., Buchmann A., Schwarz M. Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the β-catenin pathway. Toxicological Sciences. 2011;122(1):16–25. doi: 10.1093/toxsci/kfr080. PubMed DOI

Gerbal-Chaloin S., Dumé A.-S., Briolotti P., et al. The WNT/b-catenin pathway is a transcriptional regulator of CYP2E1, CYP1A2, and aryl hydrocarbon receptor gene expression in primary human hepatocytes. Molecular Pharmacology. 2014;86(6):624–634. doi: 10.1124/mol.114.094797. PubMed DOI

Kasai S., Ishigaki T., Takumi R., Kamimura T., Kikuchi H. β-Catenin signaling induces CYP1A1 expression by disrupting adherens junctions in Caco-2 human colon carcinoma cells. Biochimica et Biophysica Acta (BBA)—General Subjects. 2013;1830(3):2509–2516. doi: 10.1016/j.bbagen.2012.11.007. PubMed DOI

Vaas S., Kreft L., Schwarz M., Braeuning A. Cooperation of structurally different aryl hydrocarbon receptor agonists and β-catenin in the regulation of CYP1A expression. Toxicology. 2014;325:e31–e41. doi: 10.1016/j.tox.2014.08.010. PubMed DOI

Zhang Y., Li X.-M., Zhang F.-K., Wang B.-E. Activation of canonical Wnt signaling pathway promotes proliferation and self-renewal of rat hepatic oval cell line WB-F344 in vitro. World Journal of Gastroenterology. 2008;14(43):6673–6680. doi: 10.3748/wjg.14.6673. PubMed DOI PMC

Kawajiri K., Kobayashi Y., Ohtake F., et al. Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(32):13481–13486. doi: 10.1073/pnas.0902132106. PubMed DOI PMC

Angers S., Moon R. T. Proximal events in Wnt signal transduction. Nature Reviews Molecular Cell Biology. 2009;10(7):468–477. doi: 10.1038/nrm2717. PubMed DOI

Bisgaard H. C., Nagy P., Ton P. T., Hu Z., Thorgeirsson S. S. Modulation of keratin 14 and α-fetoprotein expression during hepatic oval cell proliferation and liver regeneration. Journal of Cellular Physiology. 1994;159(3):475–484. doi: 10.1002/jcp.1041590312. PubMed DOI

Golding M., Sarraf C. E., Lalani E.-N., et al. Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatology. 1995;22(4):1243–1253. doi: 10.1016/0270-9139(95)90635-5. PubMed DOI

Branam A. M., Davis N. M., Moore R. W., Schneider A. J., Vezina C. M., Peterson R. E. TCDD inhibition of canonical wnt signaling disrupts prostatic bud formation in mouse urogenital sinus. Toxicological Sciences. 2013;133(1):42–53. doi: 10.1093/toxsci/kft027. PubMed DOI PMC

Tsang H., Cheung T.-Y., Kodithuwakku S. P., et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) suppresses spheroids attachment on endometrial epithelial cells through the down-regulation of the Wnt-signaling pathway. Reproductive Toxicology. 2012;33(1):60–66. doi: 10.1016/j.reprotox.2011.11.002. PubMed DOI

Xu G., Zhou Q., Wan C., et al. 2,3,7,8-TCDD induces neurotoxicity and neuronal apoptosis in the rat brain cortex and PC12 cell line through the down-regulation of the Wnt/β-catenin signaling pathway. NeuroToxicology. 2013;37:63–73. doi: 10.1016/j.neuro.2013.04.005. PubMed DOI

Zhao S., Kanno Y., Nakayama M., Makimura M., Ohara S., Inouye Y. Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells. Cancer Letters. 2012;317(2):192–198. doi: 10.1016/j.canlet.2011.11.025. PubMed DOI

Wang Q., Kurita H., Carreira V., et al. Ah receptor activation by dioxin disrupts activin, BMP, and WNT signals during the early differentiation of mouse embryonic stem cells and inhibits cardiomyocyte functions. Toxicological Sciences. 2016;149(2):346–357. doi: 10.1093/toxsci/kfv246. PubMed DOI PMC

Attisano L., Wrana J. L. Signal integration in TGF-β, WNT, and Hippo pathways. F1000Prime Reports. 2013;5, article17 doi: 10.12703/p5-17. PubMed DOI PMC

Guo X., Wang X.-F. Signaling cross-talk between TGF-β/BMP and other pathways. Cell Research. 2009;19(1):71–88. doi: 10.1038/cr.2008.302. PubMed DOI PMC

Sánchez A., Fabregat I. Growth factor- and cytokine-driven pathways governing liver stemness and differentiation. World Journal of Gastroenterology. 2010;16(41):5148–5161. doi: 10.3748/wjg.v16.i41.5148. PubMed DOI PMC

Bird T. G., Lorenzini S., Forbes S. J. Activation of stem cells in hepatic diseases. Cell and Tissue Research. 2008;331(1):283–300. doi: 10.1007/s00441-007-0542-z. PubMed DOI PMC

Clark J. B., Rice L., Sadiq T., et al. Hepatic progenitor cell resistance to TGF-β1's proliferative and apoptotic effects. Biochemical and Biophysical Research Communications. 2005;329(1):337–344. doi: 10.1016/j.bbrc.2005.01.129. PubMed DOI

Ding Z.-Y., Liang H.-F., Jin G.-N., et al. Smad6 suppresses the growth and self-renewal of hepatic progenitor cells. Journal of Cellular Physiology. 2014;229(5):651–660. doi: 10.1002/jcp.24488. PubMed DOI

Nguyen L. N., Furuya M. H., Wolfraim L. A., et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology. 2007;45(1):31–41. doi: 10.1002/hep.21466. PubMed DOI

Zaher H., Fernandez-Salguero P. M., Letterio J., et al. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-β and apoptosis. Molecular Pharmacology. 1998;54(2):313–321. PubMed

Puga A., Maier A., Medvedovic M. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochemical Pharmacology. 2000;60(8):1129–1142. doi: 10.1016/S0006-2952(00)00403-2. PubMed DOI

Sahlberg C., Peltonen E., Lukinmaa P.-L., Alaluusua S. Dioxin alters gene expression in mouse embryonic tooth explants. Journal of Dental Research. 2007;86(7):600–605. doi: 10.1177/154405910708600704. PubMed DOI

Rodgarkia-Dara C., Vejda S., Erlach N., et al. The activin axis in liver biology and disease. Mutation Research—Reviews in Mutation Research. 2006;613(2-3):123–137. doi: 10.1016/j.mrrev.2006.07.002. PubMed DOI

Chen L., Zhang W., Liang H.-F., et al. Activin A induces growth arrest through a SMAD-dependent pathway in hepatic progenitor cells. Cell Communication and Signaling. 2014;12, article 18 doi: 10.1186/1478-811x-12-18. PubMed DOI PMC

Yao P., Zhan Y., Xu W., et al. Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-kappaB. Journal of Hepatology. 2004;40:391–398. doi: 10.1016/j.jhep.2003.11.001. PubMed DOI

Evarts R. P., Hu Z., Fujio K., Marsden E. R., Thorgeirsson S. S. Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth & Differentiation. 1993;4(7):555–561. PubMed

Evarts R. P., Nakatsukasa H., Marsden E. R., Hu Z., Thorgeirsson S. S. Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Molecular Carcinogenesis. 1992;5(1):25–31. doi: 10.1002/mc.2940050107. PubMed DOI

Du B., Altorki N. K., Kopelovich L., Subbaramaiah K., Dannenberg A. J. Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism. Cancer Research. 2005;65(13):5982–5988. doi: 10.1158/0008-5472.can-05-0628. PubMed DOI

Choi S. S. H., Miller M. A., Harper P. A. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces amphiregulin gene expression in the developing mouse ureter. Toxicological Sciences. 2006;94(1):163–174. doi: 10.1093/toxsci/kfl090. PubMed DOI

Kiso S., Kawata S., Tamura S., et al. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology. 2003;124(3):701–707. doi: 10.1053/gast.2003.50097. PubMed DOI

Mitchell C., Nivison M., Jackson L. F., et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. The Journal of Biological Chemistry. 2005;280(4):2562–2568. doi: 10.1074/jbc.m412372200. PubMed DOI

Miyoshi E., Higashiyama S., Nakagawa T., et al. High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis. International Journal of Cancer. 1996;68(2):215–218. doi: 10.1002/(SICI)1097-0215(19961009)68:2<215::AID-IJC13>3.0.CO;2-9. PubMed DOI

Davis J. W., II, Lauer F. T., Burdick A. D., Hudson L. G., Burchiel S. W. Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor α production. Cancer Research. 2001;61(8):3314–3320. PubMed

Patel R. D., Kim D. J., Peters J. M., Perdew G. H. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicological Sciences. 2006;89(1):75–82. doi: 10.1093/toxsci/kfi344. PubMed DOI

Mo J.-S., Park H. W., Guan K.-L. The Hippo signaling pathway in stem cell biology and cancer. EMBO Reports. 2014;15(6):642–656. doi: 10.15252/embr.201438638. PubMed DOI PMC

Yu F.-X., Guan K.-L. The Hippo pathway: regulators and regulations. Genes and Development. 2013;27(4):355–371. doi: 10.1101/gad.210773.112. PubMed DOI PMC

Lai D., Ho K. C., Hao Y., Yang X. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Research. 2011;71(7):2728–2738. doi: 10.1158/0008-5472.can-10-2711. PubMed DOI

Zhao B., Ye X., Yu J., et al. TEAD mediates YAP-dependent gene induction and growth control. Genes and Development. 2008;22(14):1962–1971. doi: 10.1101/gad.1664408. PubMed DOI PMC

Piccolo S., Dupont S., Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiological reviews. 2014;94(4):1287–1312. doi: 10.1152/physrev.00005.2014. PubMed DOI

Zhao B., Wei X., Li W., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes & Development. 2007;21:2747–2761. doi: 10.1101/gad.1602907. PubMed DOI PMC

Yu F. X., Meng Z., Plouffe S. W., Guan K. Hippo pathway regulation of gastrointestinal tissues. Annual Review of Physiology. 2015;77(1):201–227. doi: 10.1146/annurev-physiol-021014-071733. PubMed DOI

Yimlamai D., Christodoulou C., Galli G. G., et al. Hippo pathway activity influences liver cell fate. Cell. 2014;157(6):1324–1338. doi: 10.1016/j.cell.2014.03.060. PubMed DOI PMC

Zhang N., Bai H., David K. K., et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Developmental Cell. 2010;19(1):27–38. doi: 10.1016/j.devcel.2010.06.015. PubMed DOI PMC

Kowalik M. A., Saliba C., Pibiri M., et al. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology. 2011;53(6):2086–2096. doi: 10.1002/hep.24289. PubMed DOI

Fitamant J., Kottakis F., Benhamouche S., et al. YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Reports. 2015;10(10):1692–1707. doi: 10.1016/j.celrep.2015.02.027. PubMed DOI PMC

Hayashi H., Higashi T., Yokoyama N., et al. An imbalance in TAZ and YAP expression in hepatocellular carcinoma confers cancer stem cell-like behaviors contributing to disease progression. Cancer Research. 2015;75(22):4985–4997. doi: 10.1158/0008-5472.can-15-0291. PubMed DOI

Xiao H., Jiang N., Zhou B., Liu Q., Du C. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Cancer Science. 2015;106(2):151–159. doi: 10.1111/cas.12587. PubMed DOI PMC

Li H., Wolfe A., Septer S., et al. Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver International. 2012;32(1):38–47. doi: 10.1111/j.1478-3231.2011.02646.x. PubMed DOI PMC

Yang A.-T., Wang P., Tong X.-F., et al. Connective tissue growth factor induces hepatic progenitor cells to differentiate into hepatocytes. International Journal of Molecular Medicine. 2013;32(1):35–42. doi: 10.3892/ijmm.2013.1380. PubMed DOI

Kim S., Dere E., Burgoon L. D., Chang C.-C., Zacharewski T. R. Comparative analysis of AhR-mediated TCDD-elicited gene expression in human liver adult stem cells. Toxicological Sciences. 2009;112(1):229–244. doi: 10.1093/toxsci/kfp189. PubMed DOI PMC

Pande K., Moran S. M., Bradfield C. A. Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Molecular Pharmacology. 2005;67(5):1393–1398. doi: 10.1124/mol.105.010983. PubMed DOI

Knight B., Matthews V. B., Akhurst B., et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunology and Cell Biology. 2005;83(4):364–374. doi: 10.1111/j.1440-1711.2005.01346.x. PubMed DOI

Knight B., Yeoh G. C. T., Husk K. L., et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. Journal of Experimental Medicine. 2000;192(12):1809–1818. doi: 10.1084/jem.192.12.1809. PubMed DOI PMC

Umannová L., Zatloukalová J., Machala M., et al. Tumor necrosis factor-α modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver ‘stem-like’ cells. Toxicological Sciences. 2007;99(1):79–89. doi: 10.1093/toxsci/kfm149. PubMed DOI

Kabátková M., Svobodová J., Pěnčíková K., et al. Interactive effects of inflammatory cytokine and abundant low-molecular-weight PAHs on inhibition of gap junctional intercellular communication, disruption of cell proliferation control, and the AhR-dependent transcription. Toxicology Letters. 2015;232(1):113–121. doi: 10.1016/j.toxlet.2014.09.023. PubMed DOI

Šmerdová L., Svobodová J., Kabátková M., et al. Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway. Carcinogenesis. 2014;35(11):2534–2543. doi: 10.1093/carcin/bgu190. PubMed DOI

Umannová L., Machala M., Topinka J., et al. Tumor necrosis factor-α potentiates genotoxic effects of benzo[a]pyrene in rat liver epithelial cells through upregulation of cytochrome P450 1B1 expression. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2008;640(1-2):162–169. doi: 10.1016/j.mrfmmm.2008.02.001. PubMed DOI

Applicability of Scrape Loading-Dye Transfer Assay for Non-Genotoxic Carcinogen Testing

Structure-Dependent Effects of Phthalates on Intercellular and Intracellular Communication in Liver Oval Cells